tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jessica Tassan, 34 are a HOLD (26.77%), 3 are a SELL (2.36%), 90 are a BUY (70.87%).
Analyst Jessica Tassan, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 54.14% that have a potential upside of 14.86% achieved within 100 days.
Jessica Tassan’s has documented 253 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PHR, Phreesia at 04-Sep-2025.
Analyst best performing recommendations are on ACCD (ACCOLADE ).
The best stock recommendation documented was for HCAT (HEALTH CATALYST) at 9/13/2022. The price target of $11 was fulfilled within 1 day with a profit of $0.28 (2.61%) receiving and performance score of 26.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$12
$11.72 (4185.71%)
1 years 11 months 12 days ago
(17-Nov-2023)
0/1 (0%)
$4.37 (57.27%)
Hold
$0.5
$0.25 (100.00%)
$2.5
2 years 2 months 15 days ago
(14-Aug-2023)
0/5 (0%)
$3.12 (70.54%)
Buy
$0.8
$0.55 (220.00%)
$12
2 years 2 months 18 days ago
(11-Aug-2023)
0/3 (0%)
$3.48 (64.74%)
Buy
$17
2 years 2 months 18 days ago
(11-Aug-2023)
0/1 (0%)
$4.88 (40.26%)
Buy
2 years 6 months 26 days ago
(03-Apr-2023)
4/4 (100%)
$2.26 (47.68%)
338
Which stock is Jessica Tassan is most bullish on?
Which stock is Jessica Tassan is most reserved on?
What Year was the first public recommendation made by Jessica Tassan?
